Clinical Trial Update: Dasotraline Pediatric ADHD Study [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for dasotraline in pediatric ADHD shows completion across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Dasotraline (dasotraline)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2, Phase 3 | Status: COMPLETED